A citation-based method for searching scientific literature

J R Hirsch, Markus Meyer, W-G Forssmann. Eur J Med Res 2006
Times Cited: 13







List of co-cited articles
154 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
Lincoln R Potter, Andrea R Yoder, Darcy R Flora, Laura K Antos, Deborah M Dickey. Handb Exp Pharmacol 2009
344
38

Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.
Jonathan D Sackner-Bernstein, Hal A Skopicki, Keith D Aaronson. Circulation 2005
550
30

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
W S Colucci, U Elkayam, D P Horton, W T Abraham, R C Bourge, A D Johnson, L E Wagoner, M M Givertz, C S Liang, M Neibaur,[...]. N Engl J Med 2000
700
30

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions.
Lincoln R Potter, Sarah Abbey-Hosch, Deborah M Dickey. Endocr Rev 2006
700
30

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
R J Cody, S A Atlas, J H Laragh, S H Kubo, A B Covit, K S Ryman, A Shaknovich, K Pondolfino, M Clark, M J Camargo. J Clin Invest 1986
774
30


Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension.
S W John, J H Krege, P M Oliver, J R Hagaman, J B Hodgin, S C Pang, T G Flynn, O Smithies. Science 1995
505
30

Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
30

Effect of nesiritide in patients with acute decompensated heart failure.
C M O'Connor, R C Starling, A F Hernandez, P W Armstrong, K Dickstein, V Hasselblad, G M Heizer, M Komajda, B M Massie, J J V McMurray,[...]. N Engl J Med 2011
869
30


A new natriuretic peptide in porcine brain.
T Sudoh, K Kangawa, N Minamino, H Matsuo. Nature 1988
30



Mechanisms of renal hyporesponsiveness to ANP in heart failure.
A Charloux, F Piquard, S Doutreleau, G Brandenberger, B Geny. Eur J Clin Invest 2003
86
23


Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine.
P Schulz-Knappe, K Forssmann, F Herbst, D Hock, R Pipkorn, W G Forssmann. Klin Wochenschr 1988
259
23

Biochemistry of natriuretic peptides.
T G Yandle. J Intern Med 1994
137
23

Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.
Ondrej Lisy, Brenda K Huntley, Daniel J McCormick, Paul A Kurlansky, John C Burnett. J Am Coll Cardiol 2008
133
23

Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor.
B S Edwards, R S Zimmerman, T R Schwab, D M Heublein, J C Burnett. Circ Res 1988
475
23


Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects.
Candace Y W Lee, Horng H Chen, Ondrej Lisy, Suzanne Swan, Courtney Cannon, Hsiao D Lieu, John C Burnett. J Clin Pharmacol 2009
82
23

Natriuretic peptides.
E R Levin, D G Gardner, W K Samson. N Engl J Med 1998
23

M-atrial natriuretic peptide: a novel antihypertensive protein therapy.
Paul M McKie, Tomoko Ichiki, John C Burnett. Curr Hypertens Rep 2012
20
23


The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
Scott D Solomon, Michael Zile, Burkert Pieske, Adriaan Voors, Amil Shah, Elisabeth Kraigher-Krainer, Victor Shi, Toni Bransford, Madoka Takeuchi, Jianjian Gong,[...]. Lancet 2012
775
23

Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).
Jessie Gu, Adele Noe, Priya Chandra, Suliman Al-Fayoumi, Monica Ligueros-Saylan, Ramesh Sarangapani, Suzanne Maahs, Gary Ksander, Dean F Rigel, Arco Y Jeng,[...]. J Clin Pharmacol 2010
354
23

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
Milton Packer, Robert M Califf, Marvin A Konstam, Henry Krum, John J McMurray, Jean-Lucien Rouleau, Karl Swedberg. Circulation 2002
473
23

Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension.
E G Bevan, J M Connell, J Doyle, H A Carmichael, D L Davies, A R Lorimer, G T McInnes. J Hypertens 1992
128
23

CD-NP: a novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heart.
Fernando L Martin, S Jeson Sangaralingham, Brenda K Huntley, Paul M McKie, Tomoko Ichiki, Horng H Chen, Josef Korinek, Gerald E Harders, John C Burnett. PLoS One 2012
44
23

Effects of synthetic atrial natriuretic factor on renal function and renin release.
J C Burnett, J P Granger, T J Opgenorth. Am J Physiol 1984
732
23

Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
Toshio Nishikimi, Koichiro Kuwahara, Kazuwa Nakao. J Cardiol 2011
129
23

Atrial natriuretic peptide elevation in congestive heart failure in the human.
J C Burnett, P C Kao, D C Hu, D W Heser, D Heublein, J P Granger, T J Opgenorth, G S Reeder. Science 1986
919
23

Furin-mediated processing of Pro-C-type natriuretic peptide.
Chengliang Wu, Faye Wu, Junliang Pan, John Morser, Qingyu Wu. J Biol Chem 2003
151
23

Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes.
Faye Wu, Wei Yan, Junliang Pan, John Morser, Qingyu Wu. J Biol Chem 2002
121
23


Hypertension in mice lacking the proatrial natriuretic peptide convertase corin.
Joyce C Y Chan, Ole Knudson, Faye Wu, John Morser, William P Dole, Qingyu Wu. Proc Natl Acad Sci U S A 2005
193
23

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.
T Sudoh, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1990
946
23


Human B-type natriuretic peptide is not degraded by meprin A.
Deborah M Dickey, Lincoln R Potter. Biochem Pharmacol 2010
23
23

Physiological role of silent receptors of atrial natriuretic factor.
T Maack, M Suzuki, F A Almeida, D Nussenzveig, R M Scarborough, G A McEnroe, J A Lewicki. Science 1987
23





Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man.
T G Yandle, A M Richards, M G Nicholls, R Cuneo, E A Espiner, J H Livesey. Life Sci 1986
280
23

The pharmacokinetics of alpha-human atrial natriuretic polypeptide in healthy subjects.
K Nakao, A Sugawara, N Morii, M Sakamoto, T Yamada, H Itoh, S Shiono, Y Saito, K Nishimura, T Ban. Eur J Clin Pharmacol 1986
104
23


Urodilatin: a newly described member of the ANP family.
S M Feller, M Gagelmann, W G Forssmann. Trends Pharmacol Sci 1989
65
23


Urodilatin is involved in sodium homeostasis and exerts sodium-state-dependent natriuretic and diuretic effects.
M Meyer, R Richter, R Brunkhorst, E Wrenger, P Schulz-Knappe, A Kist, P Mentz, E G Brabant, K M Koch, G Rechkemmer,[...]. Am J Physiol 1996
31
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.